Preanalytical delay reduces sensitivity of quantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection

Journal of Clinical Microbiology

Volumn 49, Issue 8, 2011, Pages 3061-3064

  Doberne, David ^a   Gaur, Rajiv L ^b   Banaei, Niaz ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MITOGENIC AGENT; MYCOBACTERIUM ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INCUBATION DELAY; INCUBATION TIME; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE ASSAY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

ADULT; CLINICAL LABORATORY TECHNIQUES; HUMAN EXPERIMENTATION; HUMANS; IMMUNOASSAY; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 79960952611     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01136-11     Document Type: Article

References (21)

1. Behr, M. A., et al. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523.
2. Berthet, F. X., P. B. Rasmussen, I. Rosenkrands, P. Andersen, and B. Gicquel. 1998. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144:3195-3203.
3. Connell, T. G., M. Tebruegge, N. Ritz, P. Bryant, and N. Curtis. 2011. The potential danger of a solely interferon-γ release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children. Thorax 66:263-264.
4. Detjen, A. K., et al. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin. Vaccine Immunol. 16:1170-1175.
5. Diel, R., et al. 2011. Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37:88-99.
6. Diel, R., R. Loddenkemper, and A. Nienhaus. 2010. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137:952-968.
7. Doherty, T. M., et al. 2005. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J. Immunol. Methods 298:129-141.
8. Dominguez, M., et al. 2010. The MIT D-lab electricity-free PortaTherm incubator for remote testing with the QuantiFERON(R)-TB Gold In-Tube assay. Int. J. Tuberc. Lung Dis. 14:1468-1474.
9. Ewer, K., et al. 2006. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174:831-839. (Pubitemid 44511666)
10. Hanekom, W. A., et al. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291:185-195. (Pubitemid 39164348)
11. Herrera, V., S. Perry, J. Parsonnet, and N. Banaei. 2011. Clinical application and limitations of interferon-{gamma} release assays for the diagnosis of latent tuberculosis infection. Clin. Infect. Dis. 52:1031-1037.
12. Herrera, V., E. Yeh, K. Murphy, J. Parsonnet, and N. Banaei. 2010. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J. Clin. Microbiol. 48:2672-2676.
13. Maartens, G., and R. J. Wilkinson. 2007. Tuberculosis. Lancet 370:2030-2043.
14. Mazurek, G. H., et al. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep. 59(RR-5):1-25.
15. Menzies, D., R. Joshi, and M. Pai. 2007. Risk of tuberculosis infection and disease associated with work in health care settings. Int. J. Tuberc. Lung Dis. 11:593-605.
16. Menzies, D., M. Pai, and G. Comstock. 2007. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146:340-354.
17. Pai, M., et al. 2009. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis. 13:84-92.
18. Perry, S., et al. 2008. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin. Vaccine Immunol. 15:425-432.
19. Shanaube, K., et al. 2010. Intra-assay reliability and robustness of Quanti-FERON(R)-TB Gold In-Tube test in Zambia. Int. J. Tuberc. Lung Dis. 14:828-833.
20. Smith, S. G., et al. 2009. Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4:e7972.
21. Wang, S. H., et al. 2010. Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scand. J. Infect. Dis. 42:845-850.